ebomi
Colour theme
Sign in
Insider · CIK 0001615374

OrbiMed Capital GP V LLC

CIK 0001615374 Name as filed on the most recent filing

Filed as OrbiMed Capital GP V LLC (61)

115 transaction lines · from 61 filings · filed 2014-08-06 to 2026-04-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-04-08 Adicet Bio, Inc.
ACET 		S, Open-market sale 40,416 disposed 6.52 263,512.32 Form 4, filing 0000947871-26-000421
2026-04-08 Adicet Bio, Inc.
ACET 		S, Open-market sale 32,523 disposed 6.29 204,569.67 Form 4, filing 0000947871-26-000421
2026-04-07 Adicet Bio, Inc.
ACET 		S, Open-market sale 29,319 disposed 6.53 191,453.07 Form 4, filing 0000947871-26-000421
2026-04-07 Adicet Bio, Inc.
ACET 		S, Open-market sale 2,400 disposed 6.38 15,312.00 Form 4, filing 0000947871-26-000421
2025-10-23 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 1,000,000 disposed 1.52 1,520,000.00 Form 4, filing 0000947871-25-000927
2025-10-08 Adicet Bio, Inc.
ACET 		P, Open-market purchase 3,500,000 acquired 1.00 3,500,000.00 Form 4, filing 0000947871-25-000898
2025-10-08 Adicet Bio, Inc.
ACET 		P, Open-market purchase 1,500,000 acquired 1.00 1,500,000.00 Form 4, filing 0000947871-25-000898
2025-09-10 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 500,000 disposed 1.80 900,000.00 Form 4, filing 0000947871-25-000854
2025-06-27 Corvus Pharmaceuticals, Inc.
CRVS 		S, Open-market sale 1,176,332 disposed 4.16 4,891,894.26 Form 4, filing 0000947871-25-000636
2024-01-25 Adicet Bio, Inc.
ACET 		P, Open-market purchase 1,841,100 acquired 2.40 4,418,640.00 Form 4, filing 0000950170-24-008053
2024-01-25 Adicet Bio, Inc.
ACET 		P, Open-market purchase 1,041,700 acquired 2.40 2,500,080.00 Form 4, filing 0000950170-24-008053
2024-01-25 Adicet Bio, Inc.
ACET 		P, Open-market purchase 242,200 acquired 2.40 581,280.00 Form 4, filing 0000950170-24-008053
2023-11-22 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 87,786 disposed 2.23 195,762.78 Form 4, filing 0000947871-23-001104
2023-06-27 Adicet Bio, Inc.
ACET 		P, Open-market purchase 442,000 acquired 2.09 923,780.00 Form 4, filing 0000947871-23-000713
2023-06-27 Adicet Bio, Inc.
ACET 		P, Open-market purchase 250,000 acquired 2.09 522,500.00 Form 4, filing 0000947871-23-000713
2023-06-27 Adicet Bio, Inc.
ACET 		P, Open-market purchase 125,000 acquired 2.09 261,250.00 Form 4, filing 0000947871-23-000713
2023-06-27 Adicet Bio, Inc.
ACET 		P, Open-market purchase 58,000 acquired 2.09 121,220.00 Form 4, filing 0000947871-23-000713
2022-11-25 Tricida, Inc.
TCDA 		S, Open-market sale 3,629,226 disposed 0.22 798,429.72 Form 4, filing 0000947871-22-001208
2022-11-23 Tricida, Inc.
TCDA 		S, Open-market sale 5,617,300 disposed 0.21 1,179,633.00 Form 4, filing 0000947871-22-001208
2022-11-22 Tricida, Inc.
TCDA 		S, Open-market sale 1,034,421 disposed 0.22 227,572.62 Form 4, filing 0000947871-22-001208
2022-11-08 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 402,000 acquired 3.21 1,290,420.00 Form 4, filing 0000947871-22-001164
2022-05-26 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 26,253 disposed 15.93 418,210.29 Form 4, filing 0000947871-22-000675
2022-05-13 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 30,722 acquired 2.49 76,497.78 Form 4, filing 0000947871-22-000567
2022-05-12 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 97,094 acquired 2.35 228,170.90 Form 4, filing 0000947871-22-000567
2022-05-11 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 64,700 acquired 1.79 115,813.00 Form 4, filing 0000947871-22-000567
2022-05-10 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 24,447 acquired 1.60 39,115.20 Form 4, filing 0000947871-22-000540
2022-05-09 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 90,712 acquired 1.56 141,510.72 Form 4, filing 0000947871-22-000540
2022-05-06 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 10,200 acquired 1.63 16,626.00 Form 4, filing 0000947871-22-000540
2022-03-31 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 34,500 disposed 21.17 730,365.00 Form 4, filing 0000947871-22-000429
2022-03-30 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 75,000 disposed 22.39 1,679,250.00 Form 4, filing 0000947871-22-000429
2022-03-29 PMV Pharmaceuticals, Inc.
PMVP 		S, Open-market sale 365,000 disposed 21.52 7,854,800.00 Form 4, filing 0000947871-22-000429
2021-11-04 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 3,571,428 acquired 3.50 12,499,998.00 Form 4, filing 0000947871-21-001150
2021-11-04 Compass Therapeutics, Inc.
CMPX 		P, Open-market purchase 1,785,715 acquired 3.50 6,250,002.50 Form 4, filing 0000947871-21-001150
2021-09-20 Corvus Pharmaceuticals, Inc.
CRVS 		S, Open-market sale 1,109,644 disposed 6.09 6,757,731.96 Form 4, filing 0000947871-21-001017
2021-02-17 Corvus Pharmaceuticals, Inc.
CRVS 		P, Open-market purchase 1,285,714 acquired 3.50 4,499,999.00 Form 4, filing 0000947871-21-000249
2020-12-08 Aerpio Pharmaceuticals, Inc.
ARPO 		S, Open-market sale 21,400 disposed 1.96 41,944.00 Form 4, filing 0000947871-20-000944
2020-09-25 PMV Pharmaceuticals, Inc.
PMVP 		P, Open-market purchase 475,000 acquired 18.00 8,550,000.00 Form 4, filing 0001209191-20-052339
2020-09-25 PMV Pharmaceuticals, Inc.
PMVP 		P, Open-market purchase 475,000 acquired 18.00 8,550,000.00 Form 4, filing 0001209191-20-052339
2020-08-18 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 43,543 disposed 108.54 4,726,157.22 Form 4, filing 0000947871-20-000699
2020-08-17 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 94,900 disposed 107.49 10,200,801.00 Form 4, filing 0000947871-20-000699
2020-08-14 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 20,257 disposed 109.03 2,208,620.71 Form 4, filing 0000947871-20-000684
2020-08-13 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 29,251 disposed 109.93 3,215,562.43 Form 4, filing 0000947871-20-000684
2020-08-12 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 42,679 disposed 107.45 4,585,858.55 Form 4, filing 0000947871-20-000684
2020-08-11 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 39,877 disposed 105.78 4,218,189.06 Form 4, filing 0000947871-20-000676
2020-08-10 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 47,700 disposed 105.23 5,019,471.00 Form 4, filing 0000947871-20-000676
2020-08-07 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 28,993 disposed 106.18 3,078,476.74 Form 4, filing 0000947871-20-000676
2020-06-19 Compass Therapeutics, Inc.
NONE 		P, Open-market purchase 1,455,132 acquired 5.00 7,275,660.00 Form 4, filing 0001213900-20-015635
2020-03-06 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 500,000 disposed 83.52 41,760,000.00 Form 4, filing 0000947871-20-000208
2020-03-03 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 400,000 disposed 84.42 33,768,000.00 Form 4, filing 0000947871-20-000192
2020-03-03 Inspire Medical Systems, Inc.
INSP 		S, Open-market sale 75,000 disposed 83.21 6,240,750.00 Form 4, filing 0000947871-20-000192

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP V LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001615374

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.